6
Clinical Trials associated with Acyclovir/HydrocortisoneAn Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
To test the safety of Xerese (acyclovir and hydrocortisone)Cream 5%/1% for the treatment of recurrent cold sores in children ages 6-11yrs after 5 days of treatment.
A Randomized, Double-Blind, Active-Controlled, Subject Initiated Study Comparing ME-609 to Acyclovir Cream for Treatment of Recurrent Herpes Simplex Labialis in Immunocompromised Patients
The purpose of this study is to evaluate the episode duration of a herpes labialis recurrence in immunocompromised patients treated with ME-609 or Acyclovir.
/ Not yet recruitingNot Applicable An open label, multi-centre, phase III, subject initiated safety study of ME-609 in treatment of recurrent herpes simplex labialis in adolescents.
100 Clinical Results associated with Acyclovir/Hydrocortisone
100 Translational Medicine associated with Acyclovir/Hydrocortisone
100 Patents (Medical) associated with Acyclovir/Hydrocortisone
100 Deals associated with Acyclovir/Hydrocortisone